Figure 1. Current Pneumococcal Vaccination Guidelines.

Abbreviations: PCV13 - 13 valent conjugate pneumococcal vaccine; PPV23 - 23 valent pneumococcal polysaccharide vaccine.

¹This recommendation is for pneumococcal naïve persons

²Defined as congenital or acquired immunodeficiency, HIV infection, chronic renal failure, nephrotic syndrome, leukaemia, lymphoma, Hodgkin disease, generalized malignancy, multiple myeloma, solid organ transplant and iatrogenic immunosuppression

³Defined as sickle cell disease and other haemoglobinopathies, congenital or acquired asplenia, splenic dysfunction and splenectomy

⁴Revaccination with PPV23 not required at 5-year mark

⁵Defined as chronic heart, lung disease, liver disease or diabetes

⁶Defined as smoker, homeless or persons with alcoholism or illicit drug use

⁷ACIP (US) and NACI (Canada) recommends those with prior PPV23 vaccination are recommended to wait a year before obtaining PCV13.

⁸Germany’s recommended age is 19-59 years

⁹NZ MoH recommends PCV13 at age ≥18 years and 19-64 respectively